Steve Davis sells $4.9 million in stock - edited | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website

  • To open or close the box of links at the top of your board, click the "hide/show" button to the right of your page, as shown here:


    To view a vertical list of all your board links on a separate page, click the "View Full List" link in parentheses.

    In the meantime, we will see what we can do to bring more attention to the "hide/show" button, such as making it bigger and/or adding color to it.

    Please continue sending constructive feedback via PM to Admin or email admin@investorvillage.com. We appreciate hearing from you!

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  16116 of 16931  at  12/6/2019 8:38:27 PM  by

BelieverTim

The following message was updated on 12/6/2019 8:57:50 PM.

 In response to msg 16114 by  LINK
view thread

Re: Steve Davis sells $4.9 million in stock - edited

Davis was given 600,000 options at $19.65 on 3/17/16.  This was the price that the stock was trading at at the time.  The first of two 2016 offerings had tanked the stock earlier in the year. 25% of those 600K options became exercisable on March 15, 2017. Davis pre planned the 12/05/19 exercise date for those 150K options on August 22, 2019 when we closed at $29.21. A couple of weeks later on September 9 (my birthday) Davis announced DRP results. We then released great detail of the DRP data on 12/04/19 after market close - accompanied by the greatest PR job that we have ever done.  Sly dog or lucky dog - you pick. I think he’s solid. From the Form 4:
“1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019. 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. 3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.63 to $52.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.72 to $51.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. 5. 25% of the 600,000 shares originally subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares vest in 36 equal monthly installments thereafter.”  


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 20     Views: 629
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
16117 Re: Steve Davis sells $4.9 million in stock - edited exsoccerman 6 12/6/2019 9:12:48 PM






Financial Market Data provided by
.


Loading...